Results

Total Results: 2,691 records

Showing results for "description".

421. AHRQ Primary Care Grant Summaries: Research Profiles and Emerging Research Spotlights (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/reports/2024-annual-report/ncepcr-grant-summaries-table.pdf
     January 01, 2024 - Grant Summaries: Research Profiles and Emerging Research Spotlights Research Profiles: Title and Description … /www.ahrq.gov/ncepcr/reports/2024-annual-report/profile-p8-reed.html Research Profiles: Title and Description … Barton PhD, RN, FAAN, ANEF University of Colorado Denver Emerging Research Spotlights: Title and Description … reports/2024-annual-report/spotlight-s2-gold-ratwani.html Emerging Research Spotlights: Title and Description

422. Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Measure Narrative (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/aspirin-narrative.pdf
     December 31, 2018 - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Measure Narrative Description … Measure Type Process Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic Description

423. Blood-Pressure-Narrative (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/blood-pressure-narrative.pdf
     December 31, 2018 - Controlling High Blood Pressure Measure Narrative Description Percentage of patients 18-85 years … better quality Measure Type Process Controlling High Blood Pressure Measure Narrative Description

424. Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Measure Narrative (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/results/research/tobacco-narrative.pdf
     December 31, 2018 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Measure Narrative Description … Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Measure Narrative Description

425. Tables 11-14 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-196-section-7.pdf
     June 02, 2025 - Deviation) Proportion in Racial Groups within Sampled ZIP Codes of Residence‡ Sampled Group Description … Reporting Hispanic Ethnicity within Sampled ZIP Codes of Residence‡ Hispanic Ethnicity Sampled Group Description … Median Household Income within Sampled ZIP Codes of Residence‡ Sampled Group Description Median … Proportion of Sampled ZIP Codes Categorized as Urban‡ Sampled Group Description Urban (Mean)‡

426. Communication Assessment Guide: Appendix 2 | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/settings/hospital/candor/modules/guide5/ap2.html
     August 01, 2022 - When in doubt about whether a description should count as one or two concepts, err on the side of counting … Conventional messages deal with the intensity and complexity of the situation by avoiding a direct description … Most of the content in conventional messages consists of a description of what happened and what the

427. Urinary Incontinence Table of Contents: Launch Toolkit (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/projects/urinary/wi-intuit-launch-toolkit-contents.pdf
     June 02, 2025 - Urinary Incontinence (UI) Table of Contents: Launch Toolkit Resource Description: This document … RESOURCE LINK DESCRIPTION UI Algorithm This urinary incontinence treatment algorithm is for providers

428. CHIPRA 213: Section 2 Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-2-tech-specs.pdf
     June 02, 2025 - Table 10-A: Codes to Identify Ambulatory or Preventive Care Visits Description CPT HCPCS ICD-9-CM … 10: Anticipatory Guidance Regarding Hydroxyurea Treatment for Children with Sickle Cell Disease Description

429. Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Tables 7-10 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-tables7-10.pdf
     June 02, 2025 - Median Household Income within ZIP Codes of Residence Description Mean SD Min 25th … Proportion of ZIP Codes Categorized as Urban Description Mean SD Min 25th Percentile Median 75th

430. Hypertension Screening for Children Who Are Overweight or Obese: Tables 6-9 (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0232-tables6-9.pdf
     June 02, 2025 - Median Household Income within ZIP Codes of Residence Description Mean SD Min 25th Percentile Median … Proportion of ZIP Codes Categorized as Urban Description Mean SD Min 25th Percentile Median 75th

431. How to Report Results of the CAHPS Clinician & Group Survey (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/cahps/surveys-guidance/cg/cgkit/HowtoReportResultsofCGCAHPS080610FINAL.pdf
     August 01, 2010 - Participants in the first round struggled slightly with the length of the description of this measure … Participants did not discuss any difficulties with the description of this measure. … In rounds one and two, participants found the description to be lengthy and stated that they had to … re-read the second sentence to better understand the description. … second sentence to better understand the description.

432. Developing a Taxonomy for Coding Ambulatory Medical Errors: A Report from the ASIPS Collaborative (pdf file)
     www.ahrq.gov/downloads/pub/advances/vol2/pace.pdf
     January 01, 2004 - Based on the first 357 reports, we modified a multi-axial taxonomy to improve the description of primary … Description of harm For this paper we used a definition of harm that includes clinical harm to the … A detailed description of our approach to coding harm can be found in an ASIPS report13 and online.8 … Individual codes associated with harm Code Description Odds Ratio 95% CI Therapeutic intent 2.71 … Hierarchical constructs associated with harm Within hierarchy code description Odds Ratio 95% CI

433. Developing a Taxonomy for Coding Ambulatory Medical Errors: A Report from the ASIPS Collaborative (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Pace.pdf
     January 01, 2004 - Based on the first 357 reports, we modified a multi-axial taxonomy to improve the description of primary … Description of harm For this paper we used a definition of harm that includes clinical harm to the … A detailed description of our approach to coding harm can be found in an ASIPS report13 and online.8 … Individual codes associated with harm Code Description Odds Ratio 95% CI Therapeutic intent 2.71 … Hierarchical constructs associated with harm Within hierarchy code description Odds Ratio 95% CI

434. Technical Specifications for Section II. Detailed Measure Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-135-technical-specifications.pdf
     November 26, 2013 - Disease Measure 2: Timeliness of Antibiotic Prophylaxis for Children with Sickle Cell Disease Description … Table 2-A: Penicillins and Erythromycins for Antibiotic Prophylaxis Description Prescription Aminopenicillins

435. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
     www.ahrq.gov/policymakers/chipra/overview/background/index.html
     December 01, 2009 - Insurance Programs (SNAC)     A-4 CHIPRA HHS Federal Quality Workgroup     A-5 Public Commenters     A-6 Description … of the Modified Delphi I Scoring Process     A-7 Online Measure Nominations Template     A-8 Description

436. Designing Consumer Reporting Systems for Patient Safety Events | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/patients-families/consumer-exp/reporting/index.html
     August 01, 2022 - Description of Methods Chapter 4. Results and Key Findings Chapter 5 Chapter 6. … Description of Methods Chapter 4. Results and Key Findings Chapter 5.

437. Chapter 1. Background | Agency for Healthcare Research and Quality
     www.ahrq.gov/patient-safety/patients-families/consumer-exp/reporting/chapter1.html
     August 01, 2022 - Description of Methods Chapter 4. Results and Key Findings Chapter 5 Chapter 6. … in this report were developed in response to these questions, using the resources described in the Description

438. Development of the Patient-Centered Medical Home Item Set | Agency for Healthcare Research and Quality
     www.ahrq.gov/cahps/surveys-guidance/item-sets/PCMH/Development-PCMH-Survey.html
     November 01, 2020 - In January 2015, AHRQ published a description of these changes in a Federal Register Notice for public … For a description of the proposed changes, read: Proposed Changes to the CAHPS Clinician & Group Survey

439. Appendix 2-C. External Linking Policy | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/publications/pubcomguide/pcguide2apc.html
     June 01, 2020 - Contractors must clearly delineate external links and provide a brief description about the content of … Each AHRQ-funded website must have a page that discusses the linking policy and provides a 25-word description

440. Making Healthcare Safer Practices: 16. Venous Thromboembolism (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/venous-thromboembolism-1.pdf
     March 01, 2020 - Thromboembolism 16-3 16.1 Patient Safety Practice: Use of Aspirin for VTE Prophylaxis 16.1.1 Practice Description … for the prevention of VTE in patients undergoing major orthopedic surgery is located in the Practice Description … Author, Year Description of Patient Safety Practice Settings and Population Summary of Findings Implementation … Author, Year Description of Patient Safety Practice Study Design; Sample Size; Patient Population … for Introduction 16.1 Patient Safety Practice: Use of Aspirin for VTE Prophylaxis 16.1.1 Practice Description